Botanical species · safety record

Lobelia inflata

The EFSA Compendium of Botanicals holds 12 constituent measurements and 1 adverse-effect record for Lobelia inflata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lobelia inflata L.

12Constituent measurements
1Safety records
4Cited sources
131Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 131 licensed products naming Lobelia inflata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Fresh

Source material stated

  • Aerial parts
  • Dried aerial part(s)
  • Fresh above ground parts
  • Fruiting body
  • Fruiting body herb top
  • Grass(es)
  • Herb
  • Herb extract

What the records describe

Constituents measured

  • Lobeline7
  • Piperidine alkaloids5

Plant parts

  • Live plants8
  • Roots and other underground parts4
  • Shoot1

Preparations

  • Solvent extraction11
  • Drying (dehydration)1

Effect types

  • Systemic1

Target tissues

  • Brain1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
LobelineRoots and other underground partsSolvent extraction≤ 8.88 MilligramMass Spectroscopy and hyphenated methods without chromatographyResolve DOI
LobelineLive plantsSolvent extraction≤ 25.04 MicrogramMass Spectroscopy and hyphenated methods without chromatographyResolve DOI
LobelineLive plantsSolvent extraction≥ 21.48 MicrogramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
LobelineRoots and other underground partsSolvent extraction≥ 5.08 MilligramMass Spectroscopy and hyphenated methods without chromatographyResolve DOI
LobelineLive plantsUnspecifiedResolve DOI
LobelineLive plantsSolvent extraction≥ 21.48 MicrogramMass Spectroscopy and hyphenated methods without chromatographyResolve DOI
LobelineLive plantsSolvent extraction≤ 25.04 MicrogramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Piperidine alkaloidsRoots and other underground partsSolvent extraction≥ 0.29 MilligramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Piperidine alkaloidsShootSolvent extractionHPLC-MS/MSResolve DOI
Piperidine alkaloidsLive plantsSolvent extraction≥ 0.62 MilligramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Piperidine alkaloidsLive plantsSolvent extraction≤ 0.66 MilligramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI
Piperidine alkaloidsRoots and other underground partsSolvent extraction≤ 0.31 MilligramColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
SystemicBrainLive plantsDrying (dehydration)Rabbit (as animal)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Banyai, Peter., Vojnich, Viktor Jozsef., Mathe, Akos., Kursinszki, Laszlo., Szoke, Eva. Enhancement of the anti-addictive lobeline and related alkaloid production of in vitro micropropagated Lobelia inflata L. . In vitro cellular & developmental biology-plant, 2014, vol. 50, no. 6, p. 760-765. DOI
  2. Kursinszki, Laszlo., Szoke, Eva. HPLC-ESI-MS/MS of brain neurotransmitter modulator lobeline and related piperidine alkaloids in Lobelia inflata L . Journal of mass spectrometry, 2015, vol. 50, no. 5, p. 727-733. DOI
  3. Johnson, H. Case of suspected poisoning by lobelia inflata: With the appearances after death. British medical journal, 1858, vol. s4-1, no. 77, p. 493-495. DOI
  4. da Costa E Silva, Liana Dantas., Rodrigues, Laise Carla Lima Verde., Dos Santos, Viviane Ramos., da Costa Allgayer, Mariangela., de Barros Falcao Ferraz, Alexandre., Rolla, Helena Campos., Pereira, Patricia., Picada, Jaqueline Nascimento. Evaluation of mutagenic and genotoxic activities of lobeline and its modulation on genomic instability induced by ethanol. . Life sciences, 2014, vol. 103, no. 2, p. 73-8. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue